Capsule production and growth phase influence binding of complement to Staphylococcus aureus
about
Staphylococcus aureus surface protein SdrE binds complement regulator factor H as an immune evasion tacticHost airway proteins interact with Staphylococcus aureus during early pneumoniaComplement evasion by human pathogens.Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection.Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infectionOverproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence.Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia.Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi.Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB.Complement activation influences Staphylococcus aureus adherence to endothelial cellsStaphylococcus aureus capsular polysaccharides.Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats.Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of DiseaseHyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus.D-Alanylation of Teichoic Acids and Loss of Poly-N-Acetyl Glucosamine in Staphylococcus aureus during Exponential Growth Phase Enhance IL-12 Production in Murine Dendritic Cells.Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.New potential role of serum apolipoprotein E mediated by its binding to clumping factor A during Staphylococcus aureus invasive infections to humans.MsaB activates capsule production at the transcription level in Staphylococcus aureus.Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor IEvasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.The role of microbial polysaccharides in host-pathogen interactionBacterial Surfaces: Front Lines in Host-Pathogen Interaction.The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis.Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis.A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy.Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis.Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway.Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus.Complement regulator C4BP binds to Staphylococcus aureus surface proteins SdrE and Bbp inhibiting bacterial opsonization and killing.Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.Discriminating the hemolytic risk of blood type A plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay.Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.
P2860
Q28729029-E5D18313-8E24-41E8-8E9F-1A1087714158Q30481363-4EA1AA01-F4CA-4752-BF96-15252F563630Q33623972-261B4563-D92E-42ED-A027-5190FFADB76FQ33719836-5C70B58B-DE69-4657-B84C-ABF4779AE243Q33788238-F82FDFAC-18E3-44E3-8512-BA8261FBD890Q33795274-6E034D28-4054-4CBC-8B37-73EF53A6C783Q33899407-CB51208C-F5DC-4EB3-B8CC-BA63560FE437Q34033337-E41908E3-5B8D-4D2D-8470-9EAC167EF78CQ34126226-3F87ADF7-8C3B-4955-94AB-155BC125448CQ34238754-4B04C648-901C-4CDB-8F3E-A08F68F4B621Q34463131-CA55B187-55A7-4627-8E5C-8DE74E7D6C63Q34492747-2E8D28BE-D77F-4991-9DF2-F305D33C6118Q34529614-A68C1EB1-CD3F-4A97-A70B-3B2A006E0A9AQ34581644-DF3155C5-3A9A-4B6E-BCB0-96D937AC36CDQ34674839-0290876B-B7CE-49B5-9212-1989AD863416Q34714048-71C49782-E700-4E25-A9FA-80CE57922212Q35630504-03BEDB5C-FF8C-49E9-8EC6-C3F8C1EDD357Q35701952-2E7C3CD1-18C0-4BB1-BD70-84F8DF6D60DFQ35862436-8DD01568-2F90-4D5F-92B5-CF7A9DC0B6AFQ35893898-19FACDC5-A804-4442-B71B-09DD260E6AF6Q35922364-1442249A-90BA-4D9D-B1D9-7288EC72195DQ36138021-999A36CE-1BF9-469F-A0E9-F17FF6614ABBQ36871854-107BC8AE-20C0-466A-B7D9-4EAAC4598EBEQ36966028-D112168A-B869-431B-90AD-5BB2AB19E97DQ37427640-1C884AFF-2C44-4AE1-8013-9F810C16F54BQ37435894-5BEF9B29-EB83-4056-81CA-4577208EC95DQ37671492-480E7B53-BEB0-4C04-9F91-586F1CB9F5A4Q37800370-96CF71C4-4D9F-4340-9ACD-9C44CDDD1F14Q38837720-DB5F01DD-98B2-459F-AC09-5CAB3894E73CQ38876259-CC99BE62-211E-4CA4-8C09-DAC99B2313FBQ39896801-B998C09D-8DBB-4F66-8BA0-23AE3CA183A3Q39950464-F4C7E865-2598-4DDE-9C96-D634F5AD7D8CQ41428438-60B1A30A-8E0D-4382-B416-38B0535DEA30Q41528685-B2E868C5-3269-483C-BD6B-63DE14CB2447Q41869157-98E72145-133F-407E-A893-4D6251A25C99Q41871463-5202F197-FD07-4F88-8D9E-B3D4B7B27B3FQ41902927-D2024A72-2F96-4182-87B6-F4D1AC61A474Q45035787-E6C9F68E-61F9-4060-868A-E2B21F82FF99Q45049365-D8BEA05C-515E-43E2-8BAA-EA5F38D035C6Q52327307-34B1BC8F-A123-4C02-B665-F6BD23759324
P2860
Capsule production and growth phase influence binding of complement to Staphylococcus aureus
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Capsule production and growth ...... ement to Staphylococcus aureus
@ast
Capsule production and growth ...... ement to Staphylococcus aureus
@en
Capsule production and growth ...... ment to Staphylococcus aureus.
@nl
type
label
Capsule production and growth ...... ement to Staphylococcus aureus
@ast
Capsule production and growth ...... ement to Staphylococcus aureus
@en
Capsule production and growth ...... ment to Staphylococcus aureus.
@nl
prefLabel
Capsule production and growth ...... ement to Staphylococcus aureus
@ast
Capsule production and growth ...... ement to Staphylococcus aureus
@en
Capsule production and growth ...... ment to Staphylococcus aureus.
@nl
P2093
P2860
P1476
Capsule production and growth ...... ement to Staphylococcus aureus
@en
P2093
P2860
P304
P356
10.1128/IAI.69.11.6796-6803.2001
P407
P577
2001-11-01T00:00:00Z